http://www.diamyd.com/ Latest Press Releases and Financial Reports from Diamyd Medical. Copyright 2013. All rights reserved. http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1335349 The Chairman of Diamyd Medical, Anders Essen-Mller, has today bought 1,429,656 shares in Diamyd Medical and his holdings in Diamyd Medical amounts after the transaction to 479,292 series A-shares and 1,617,397 series B-shares, representing approximately 21% of the capital and about 45% of the... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1335349 Fri, 17 May 2013 17:23:46 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1335344 Styrelseordfranden i Diamyd Medical AB, Anders Essen-Mller, har idag kpt 1429 656 aktier i Diamyd Medical och hans innehav i Diamyd Medical uppgr drmed efter transaktionen till 479 292 A-aktier och 1 617 397 B-aktier, vilket motsvarar cirka 21 % av kapitalet och cirka 45 % av rsterna. http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1335344 Fri, 17 May 2013 17:11:05 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1332961 Diabetes has developed into a major global problem. The disorder is affecting younger and younger people and complications related to diabetes are currently among the most common causes of death in many countries. In conjunction with the spin-out of the new Diamyd Medical from the Parent Company in... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1332961 Wed, 15 May 2013 17:35:52 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1332859 Diabetes har utvecklats till ett stort globalt problem. Sjukdomen drabbar allt yngre och komplikationer relaterade till diabetes är idag en av de vanligaste dödsorsakerna i Sverige. I samband med att nya Diamyd Medical knoppades av från moderbolaget i april 2013 bildades ett renodlat svenskt... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1332859 Wed, 15 May 2013 15:57:06 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1331288 Diamyd Medical har slutit ett nytt exklusivt licensavtal med University of California i Los Angeles (UCLA) avseende en patentportfölj på terapeutisk användning av GABA (gammaaminosmörsyra) vid typ 1-diabetes och andra inflammatoriska tilstånd som vid typ 2-diabetes, metabolt syndrom och... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1331288 Tue, 14 May 2013 15:15:56 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1331290 Diamyd Medical has concluded a new exclusive licensing agreement with the University of California in Los Angeles (UCLA) relating to a patent portfolio for the therapeutic use of GABA (gamma-aminobutyric acid) in connection with type 1 diabetes and other inflammatory disorders such as type 2... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1331290 Tue, 14 May 2013 15:15:56 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1310033 Vid en extra bolagsstämma den 22 april 2013 i Diamyd Medical AB beslutades att dotterbolaget Diamyd Therapeutics AB delas ut till aktieägarna tillsammans med diabetesverksamheten och bolaget byter samtidigt namn till Diamyd Medical AB. Det nya Diamyd Medical behåller webadressen www.diamyd.com.... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1310033 Mon, 22 Apr 2013 08:30:00 http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1310035 At an Extraordinary General Meeting of Diamyd Medical AB on April 22, 2013, it was decided to distribute the subsidiary Diamyd Therapeutics AB with the diabetes operations to the shareholders. At the same time the company assumes the name Diamyd Medical AB. The new Diamyd Medical will keep the web... http://www.diamyd.com/docs/pressClip.aspx?section=investor&ClipID=1310035 Mon, 22 Apr 2013 08:30:00